Ebola virus vaccine may enter clinical testing

  Anthony Fauci, an immunologist at the National Institutes of Health, said he is leading a research team to develop a new vaccine that can prevent Ebola virus infection. Realistic verification is completely effective in monkeys. It will be held in September for human clinical trials.

  Anthony is not the only expert to propose a plan to prevent Ebola. While hoping to prevent Ebola, another problem has arisen.

  So far, about 1,400 people have been infected with Ebola virus, but there is no reliable solution to prevent and treat this deadly virus. Infected people will eventually die in shock, because the virus can invade the liver in the body and destroy the formation of liver cells, thereby affecting blood coagulation. Since blood pressure becomes very low when small blood clots are formed in the blood vessels, the only way is to improve blood circulation by ingesting proper hydration and nutrients in the early stages.

  Currently, health professionals are developing some promising interventions that have been tested to have high efficacy against Ebola in monkeys. The Ebola virus causes monkeys to show the same symptoms as humans. However, for the use of certain viruses, most vaccines and drugs do not meet the US Food and Drug Administration (FDA) standards.